IVF Services Market Overview:

Global IVF services market generated $10,587 million in 2017 and is projected to reach $22,467 million by 2025, growing at a CAGR of 9.8% from 2018 to 2025. In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a womans ovaries and fertilizing them with sperm outside the body, in vitro.

The global IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in IVF success rate, and rise in disposable income worldwide. However, high cost, complications associated with IVF treatment, and low awareness level for IVF in some under developed regions hinder the growth of the IVF services market. Conversely, upsurge in fertility tourism, increase in number of fertility clinics, and growth opportunities in the emerging markets make way for IVF services market development in the future.

The global IVF services market is segmented based on cycle type, end user, and region. Based on cycle type, the market is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, the IVF services industry is classified as fertility clinics, hospitals, surgical centers and clinical research institutes. Region wise, the IVF services market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, Denmark, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, Thailand, New Zealand, South Korea and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).

Segment review

The global IVF services market by cycle type segment is sub-segmented into fresh (non-donor) IVF cycles, thawed (non-donor) IVF cycles, and donor egg IVF cycles. The fresh IVF cycles (non-donor) is the largest segment, accounted for two-thirds of the total IVF cycles in 2017. The fresh embryo IVF cycle begins with the ovarian stimulation, which is followed by retrieval of all eggs from the patient. These eggs are reinserted to create an embryo; these embryos are transferred back in the patient. Any remaining good quality embryos are frozen, which can be used in the future frozen IVF cycles.

Fertility clinics and specialty hospital play a crucial role in providing IVF treatments to couples seeking assistance for infertility treatments. Fertility clinics provide technologically advanced IVF treatments toward patients having fertility problems. Availability of a wide range of fertility treatments under one roof coupled with government reimbursements majorly drive the growth of fertility clinic end user segment of the global in vitro fertilization market.

In developing regions of Africa, most of the IVF requirements are imported and can be used only once in each cycle. According to the University of Benin (Nigeria), the incidence of infertility in Nigeria is about 25% as compared to 1015% in the U.S. and the UK. IVF procedures have helped couples to deal with this high infertility rates. In addition, low IVF treatment cost and rise in trends of fertility tourism in the South Africa further drive the growth of the in vitro fertilization market in Africa. On the other side, lack of financial resources, poor income, lack of awareness regarding IVF, inadequacy of healthcare services coverage, and dearth of trained healthcare professionals hamper the growth of the in vitro fertilization market in the underdeveloped countries in Africa.

Request for Table of Content

The adoption of IVF procedure is expected to increase due to rise in infertile population across the world and growth in fertility tourism in the developing countries. Additionally, increase in success rate of IVF, surge in disposable income, and rise in trend of delayed pregnancies are expected to further drive the market growth in the coming future. However, complications associated with the use of IVF and higher cost are expected to hinder the market growth.

Asia-Pacific is expected to remain dominant during the forecast period, followed by Europe. Emerging fertility tourism destinations such as India, Thailand, Japan, and Australia are chiefly responsible for the growth of Asia-Pacific region, mainly due to the availability of skilled workforce and rise in healthcare awareness in these nations. In addition, Increased government support and national fertility programs and favorable regulatory policies are projected to supplement the growth of the European IVF services market. Efforts of HFEA and the acceptance of three parent IVF methods in countries, such as UK, would further support the growth of the Europe IVF services market.

Japan, China, U.S., India, and France are the most prominent countries for IVF procedures. This is due to the affordability and reimbursements available for IVF cycles. Countries across Western Europe exhibit an alleviated response toward IVF procedures owing to favorable regulations and lesser ethical obligations. However, growth of the IVF services market in Latin America and some parts of Middle East is hampered due to the presence of ethical issues and lack of regulatory policies.